See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: May 12, 2006

Psoriasis and Psoriatic Disorders Seborrheic Dermatitis Ovarian Cancer

(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:

Psoriasis and Psoriatic Disorders

Radiant Research is evaluating an investigational medication for psoriasis. You may qualify if you are 18 or older and have been diagnosed with plaque-type psoriasis. Participants will receive all study-related exams and investigational medication at no cost, and may be compensated for time and travel. The research site is in Philadelphia, Penn.

More information

Please see http://www.centerwatch.com/patient/studies/cat126.html.

-----

Seborrheic Dermatitis

People with dandruff may qualify for a 4-week research study of a topical investigational medication. Candidates 12 and older with diagnosed seborrheic dermatitis may be eligible. Qualified volunteers will receive free evaluations, medication, and compensation. The research site is in Johnston, R.I.

More information

Please see http://www.centerwatch.com/patient/studies/cat728.html.

-----

Kidney Cancer

This study will evaluate the safety and effectiveness of GW786034 in adults with locally recurrent or metastatic clear-cell renal cell carcinoma (RCC). Volunteers diagnosed with RCC who have adequate bone marrow and renal function may qualify. Participants cannot have had major surgery, radiotherapy, or immunotherapy within the last 28 days, and women cannot be pregnant or lactating. The research sites are worldwide.

More information

Please see http://www.centerwatch.com/patient/studies/cat33.html.

-----

Copyright 2006 CenterWatch. All rights reserved.

Consumer News
undefined
undefinedundefined